KHK4827
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Systemic Sclerosis
Conditions
Systemic Sclerosis
Trial Timeline
Oct 6, 2017 → Mar 31, 2025
NCT ID
NCT04368403About KHK4827
KHK4827 is a phase 1 stage product being developed by Kyowa Kirin for Systemic Sclerosis. The current trial status is completed. This product is registered under clinical trial identifier NCT04368403. Target conditions include Systemic Sclerosis.
What happened to similar drugs?
10 of 20 similar drugs in Systemic Sclerosis were approved
Approved (10) Terminated (4) Active (7)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04368403 | Phase 1 | Completed |
| NCT01782924 | Phase 3 | Completed |
| NCT01782937 | Phase 3 | Completed |
Competing Products
20 competing products in Systemic Sclerosis